NEA 14 Gp, Ltd., 10% Owner at Adaptimmune Therapeutics PLC (ADAP), bought 12,870,000 shares at $0.70 ($9.0M) on 2017-03-27, disclosed to the SEC on 2017-03-28.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| Filing → |
| TCON | BUY | 2018-03-27 | $3.8M | — | Filing → |
| ADAP | BUY | 2018-03-23 | $4.8M | — | Filing → |
| MRSN | BUY | 2017-07-06 | $15.0M | — | Filing → |